Orit Freedman
- Oncology top 2%
- Pulmonary and Respiratory Medicine top 2%
- Cancer Research top 2%
- Genetics top 5%
- Genetics top 5%
- Co-authors
- Eitan AmirBoštjan ŠerugaD. Gareth EvansIn Hae ParkShin‐Cheh ChenMartin FrenzelMasakazu ToiOlivier Trédan
- Topics
- Breast Cancer Treatment Studies (16 papers)Cancer Treatment and Pharmacology (12 papers)HER2/EGFR in Cancer Research (8 papers)
- Partner nations
- CanadaUnited KingdomUnited States
In The Last Decade
Orit Freedman
39 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Oncology 1.5k
- Pulmonary and Respiratory Medicine 1.3k
- Cancer Research 718
- Genetics 344
- Genetics 286
Countries citing papers authored by Orit Freedman
This map shows the geographic impact of Orit Freedman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Orit Freedman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Orit Freedman more than expected).
Fields of papers citing papers by Orit Freedman
This network shows the impact of papers produced by Orit Freedman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Orit Freedman. The network helps show where Orit Freedman may publish in the future.
Co-authorship network of co-authors of Orit Freedman
This figure shows the co-authorship network connecting the top 25 collaborators of Orit Freedman. A scholar is included among the top collaborators of Orit Freedman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Orit Freedman. Orit Freedman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 21 | |
| 3 | 3 | |
| 4 | MONARCH 3: Abemaciclib As Initial Therapy for Advanced Breast Cancerbreakdown → | 1125 |
| 5 | 8 | |
| 6 | 28 | |
| 7 | 30 | |
| 8 | 28 | |
| 9 | 39 | |
| 10 | 6 | |
| 11 | 31 | |
| 12 | 139 | |
| 13 | 6 | |
| 14 | 28 | |
| 15 | 2 | |
| 16 | 6 | |
| 17 | 12 | |
| 18 | 35 | |
| 19 | 14 | |
| 20 | 15 |
About Orit Freedman
Orit Freedman is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 40 papers that have together received 2.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (16 papers), Cancer Treatment and Pharmacology (12 papers) and HER2/EGFR in Cancer Research (8 papers). The work is most often cited by research in Oncology (1.5k citations), Cancer Research (718 citations) and Pulmonary and Respiratory Medicine (1.3k citations). Orit Freedman has collaborated with scholars based in Canada, United Kingdom and United States. Frequent co-authors include Eitan Amir, Boštjan Šeruga, D. Gareth Evans, In Hae Park, Shin‐Cheh Chen, Martin Frenzel, Masakazu Toi, Olivier Trédan, Luís Manso and Tammy Forrester. Their work appears in journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.